Literature DB >> 2460533

Tumor necrosis factor-alpha and tumor necrosis factor-beta (lymphotoxin) stimulate the production of granulocyte-macrophage colony-stimulating factor, macrophage colony-stimulating factor, and IL-1 in vivo.

K Kaushansky1, V C Broudy, J M Harlan, J W Adamson.   

Abstract

A number of cell types have been shown to elaborate hematopoietic growth factors in response to inflammatory mediators in vitro. To determine if this response occurs in vivo, we have administered levels of TNF-alpha and TNF-beta (lymphotoxin) found during an inflammatory reaction to mice. Using Northern blot analysis to detect tissue levels of hematopoietic growth factor-specific transcripts, and specific biologic and immunologic assays to detect the presence of colony-stimulating factors in the serum, we have found that TNF-alpha and TNF-beta induce the transcription and production of granulocyte-macrophage-CSF, macrophage-CSF, and IL-1. These findings provide an in vivo mechanism for the hematopoietic response to inflammation.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2460533

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  18 in total

1.  Bone marrow transplantation reproduces the tristetraprolin-deficiency syndrome in recombination activating gene-2 (-/-) mice. Evidence that monocyte/macrophage progenitors may be responsible for TNFalpha overproduction.

Authors:  E Carballo; G S Gilkeson; P J Blackshear
Journal:  J Clin Invest       Date:  1997-09-01       Impact factor: 14.808

2.  Identification of lymphotoxin and tumor necrosis factor in multiple sclerosis lesions.

Authors:  K Selmaj; C S Raine; B Cannella; C F Brosnan
Journal:  J Clin Invest       Date:  1991-03       Impact factor: 14.808

3.  Inter-individual differences in cytokine release in patients undergoing cardiac surgery with cardiopulmonary bypass.

Authors:  A Roth-Isigkeit; L Hasselbach; E Ocklitz; S Brückner; A Ros; H Gehring; P Schmucker; L Rink; M Seyfarth
Journal:  Clin Exp Immunol       Date:  2001-07       Impact factor: 4.330

4.  Generation and characterization of a neutralizing rat anti-rmTNF-alpha monoclonal antibody.

Authors:  R Lucas; K Heirwegh; A Neirynck; L Remels; H Van Heuverswyn; P De Baetselier
Journal:  Immunology       Date:  1990-10       Impact factor: 7.397

5.  Cytokine signature profiles in acquired aplastic anemia and myelodysplastic syndromes.

Authors:  Xingmin Feng; Phillip Scheinberg; Colin O Wu; Leigh Samsel; Olga Nunez; Courtney Prince; Rebecca D Ganetzky; J Philip McCoy; Jaroslaw P Maciejewski; Neal S Young
Journal:  Haematologica       Date:  2010-12-15       Impact factor: 9.941

6.  Tumor necrosis factor alpha and the anemia associated with murine malaria.

Authors:  K L Miller; P H Silverman; B Kullgren; L J Mahlmann
Journal:  Infect Immun       Date:  1989-05       Impact factor: 3.441

7.  Anti-(tumor necrosis factor) alters the response of human monocytes to liposomal muramyl tripeptide.

Authors:  M Maeda; T Asano; E S Kleinerman
Journal:  Cancer Immunol Immunother       Date:  1993-08       Impact factor: 6.968

8.  A phase II combination trial with recombinant human tumor necrosis factor and gamma interferon in patients with colorectal cancer.

Authors:  W Fiedler; W Zeller; C J Peimann; H J Weh; D K Hossfeld
Journal:  Klin Wochenschr       Date:  1991-04-04

9.  Adenovirus E3 14.7K protein functions in the absence of other adenovirus proteins to protect transfected cells from tumor necrosis factor cytolysis.

Authors:  T M Horton; T S Ranheim; L Aquino; D I Kusher; S K Saha; C F Ware; W S Wold; L R Gooding
Journal:  J Virol       Date:  1991-05       Impact factor: 5.103

10.  Increased macrophage colony-stimulating factor in neonatal and adult autoimmune MRL-lpr mice.

Authors:  M A Yui; W H Brissette; D C Brennan; R P Wuthrich; V E Rubin-Kelley
Journal:  Am J Pathol       Date:  1991-08       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.